The treatment combines Clearmind s MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc s Palmitoylethanolamide , the active ingredient of its proprietary. | June 16, 2023
Tel Aviv, Israel / Vancouver, Canada, May 22, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | May 22, 2023
Tel Aviv, Israel / Vancouver, Canada, May 19, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | May 19, 2023
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv, Israel / Vancouver, Canada, May 17, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery. | May 17, 2023